| Literature DB >> 32708849 |
Tirza Ecclesia Orowitz1, Patria Pari Agnes Ago Ana Sombo1, Driyanti Rahayu1, Aliya Nur Hasanah1.
Abstract
Molecularly imprinted polymers (MIPs) are specific crosslinked polymers that exhibit binding sites for template molecules. MIPs have been developed in various application areas of biology and chemistry; however, MIPs have some problems, including an irregular material shape. In recent years, studies have been conducted to overcome this drawback, with the synthesis of uniform microsphere MIPs or molecularly imprinted microspheres (MIMs). The polymer microsphere is limited to a minimum size of 5 nm and a molecular weight of 10,000 Da. This review describes the methods used to produce MIMs, such as precipitation polymerisation, controlled/'Living' radical precipitation polymerisation (CRPP), Pickering emulsion polymerisation and suspension polymerisation. In addition, some green chemistry aspects and future perspectives will also be given.Entities:
Keywords: controlled/‘living’ radical precipitation polymerisation; microsphere polymer; molecularly imprinted microsphere; pickering emulsion polymerisation; precipitation polymerisation; suspension polymerisation
Mesh:
Substances:
Year: 2020 PMID: 32708849 PMCID: PMC7397203 DOI: 10.3390/molecules25143256
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Applications of molecularly imprinted microspheres (MIMs).
| Application | Template | Monomer and Crosslinker | Polymerisation Technique | References |
|---|---|---|---|---|
| Selective Drug and Metabolite Recognition | 17β-estradiol | MAA, EGDMA, TRIM | PP | [ |
| 4-VP, AM, TRIM | ATRPP | [ | ||
| MAA, EGDMA | PE | [ | ||
| Theophylline | MAA, EGDMA, TRIM | PP | [ | |
| MAA, DVB | [ | |||
| Caffeine | MAA, EGDMA, TRIM | PP | [ | |
| Naproxen, Diclofenac, Toltrazuril | 4-VP, MAA, HEMA, MAAm, EGDMA, TRIM, DVB | PP | [ | |
| Estradiol (E2) | 4-VP, EGDMA | PP | [ | |
| Kaempferol | 4-VP, EGDMA | PP | [ | |
| Terbutylazine | MAA, EGDMA | PP | [ | |
| Enrofloxacine | MAA, HEMA, DVB, EGDMA, TRIM | PP | [ | |
| Nicotine | MAA, TFMAA, DVB | PP | [ | |
| MAA, EDGMA | RAFTPP | [ | ||
| MAA, TRIM | PP | [ | ||
| AM, BDDA | PP | [ | ||
| Cinchonidine | MAA, HEMA, DVB | PP | [ | |
| Morphine | MAA, TRIM | PP | [ | |
| Cinnamic Acid | AA, DVB | PP | [ | |
| Piperine | AA, EGDMA | PP | [ | |
| Mannose-tryptophan | MMA, DVB | PP | [ | |
| 2,4-diamino-6-methyl-1,3,5-triazine, cyromazine, trimethoprim | MAA, DVB | PP | [ | |
| Sulfamethazine | 4-VP, HEMA, EGDMA | ATRPP | [ | |
| Glutathione | 4-VP, EGDMA | ILRPP | [ | |
| Thymopentin | p-CMS, VI, EGDMA | ILRPP | [ | |
| Vanillin | MAA, EDGMA | RAFTPP | [ | |
| Propranolol | MAA, DVB | PP | [ | |
| MPABA, NIPAAm, EGDMA | RAFTPP | [ | ||
| 4-VP, NIPAAm, MPABA, DMAEMA, EGDMA | [ | |||
| MAA, EGDMA | [ | |||
| MAA, HEMA, EGDMA | [ | |||
| Tetracycline | MAA, HEMA, AnHEMA, EGDMA | RAFTPP | [ | |
| MAA, EGDMA | [ | |||
| Quercetin | 2-VP, EGDMA | RAFTPP | [ | |
| Aristolochic Acid I | AA, EGDMA | RAFTPP | [ | |
| Isopropylaminopropanediol | MAA, EGDMA, AIBN | PE | [ | |
| Erythromycin | MAA, EGDMA | SP | [ | |
| YPLG | MAA, EGDMA | SP | [ | |
| Controlled Drug Release | Paclitaxel | MAA, EGDMA | RAFTPP | [ |
| Adhenosine 5′-monophosphate | DMAEM, NIPAAm, MBAM | PE | [ | |
| Vancomycin | HEMA, DEAEMA | PP | [ | |
| Sunitib | MAA | PP | [ | |
| 1,4-dimethyl-6-hydroxy-9 | MAA, EGDMA | PP | [ | |
| 1-(1-naphthyl)ethylamine | Macrocyclic | SP | [ | |
| Environmental Contaminants | Tebuconazole | 4-VP, EGDMA | PP | [ |
| Bisphenol A | 4-VP, EGDMA | PP | [ | |
| ATRPP | [ | |||
| PE | [ | |||
| 4-VP, MAA, EGDMA, TRIM | PP | [ | ||
| 4-VP, DVB | PE | [ | ||
| Monocrotophos | MAA, EGDMA | PP | [ | |
| Difenoconazole | HPMA, EGDMA | PP | [ | |
| Azoxystrobin | HPMA, EGDMA | PP | [ | |
| Carbaryl | MAA, EGDMA | PP | [ | |
| Di(2-ethylhexyl)phthalate | MAA, EGDMA, TRIM | PP | [ | |
| Simetryne | ABA, DVB | PP | [ | |
| Cyhalothrin | AM, EGDMA | PP | [ | |
| Polystyrene | MAA, DVB | PP | [ | |
| IL, EGDMA | PP | [ | ||
| Diclofenac | 2-VP, EGDMA | PP | [ | |
| 2,4-Dichlorophenoxy- acetic acid | MAzoPy, EGDMA | ATRPP | [ | |
| 4-VP, NIPAAm, EGDMA | ILRPP | [ | ||
| 4-VP, EGDMA | RAFTPP | [ | ||
| 4-VP, NIPAAm, EGDMA | [ | |||
| 4-VP, HEMA, EGDMA | [ | |||
| Pyrazosulfuron- | MAA, 4-VP, AA, EGDMA, DVB | RAFTPP | [ | |
| MAA, EGDMA | [ | |||
| Sensor | Dipyridamole | MAA, EGDMA | PP | [ |
| Enrofloxacine | MAA, HEMA, DVB, EGDMA | PP | [ | |
| MISPE | 17β-estradiol | 4-VP, EGDMA | PP | [ |
| 4-aminopyridine | MAA, EGDMA | SP | [ | |
| Extraction From Natural Ingredients or Food | Curcumin | 4-VP, MAA, MAM, DVB | PP | [ |
| Dimethoate | MAA, MMA, AM, EGDMA | PP | [ | |
| Gallic Acid | AA, EGDMA | PP | [ | |
| Caffeic Acid | 4-VP, DVB | PP | [ | |
| Glutathione | MAA, DVB | PP | [ | |
| Atrazine | MAA, EGDMA | RAFTPP | [ | |
| Matrine | MAA, EGDMA | PE | [ | |
| Melamine | MAA, EGDMA | SP | [ | |
| Chloramphenicol | DEAEM, EGDMA | SP | [ |
PP, Precipitation Polymerisation; ATRPP, Atom Transfer Radical Precipitation Polymerisation; ILRPP, Iniferter-induced ‘Living’ Radical Precipitation Polymerisation; RAFTPP, Reversible Addition-Fragmentation chain Transfer Precipitation Polymerisation; PE, Pickering Emulsion polymerisation; SP, Suspension Polymerisation; MAA, methacrylic acid; HEMA, 2-hydroxyethyl methacrylate; DVB, divinylbenzene; EGDMA, ethylene glycol dimethacrylate; TRIM, trimethylolpropane trimethacrylate; TFMAA, 2-(trifluoromethyl)acrylic acid; HPMA, 2-hydroxypropyl methacrylate; AM, acrylamide; BDDA, 1,4-butanediyl diacrylate; 4-VP, 4-vinylpyridine; MAM, methacrylamide; MMA, methyl methacrylate; ABA, allobarbital; AA, acryic acid; IL, 3-(anthracen-9-ylmethyl)-1-vinyl-1H-imidazol-3-ium chloride; 2-VP, 2-vinylpyridine; MAAm, methacrylamide; MAzoPy, 4-((4-methacryloyloxy)phenylazo)pyridine; p-CMS, 4-(chloromethyl) styrene; VI, 1-vinylimidazole; MPABA, 4-((4-Methacryloyloxy)phenylazo) benzoic acid; DMAEM, 2-(dimethylamino)ethyl methacrylate; AnHEMA, (2-hydro-xyethyl anthrancene-9-carboxylate) methacrylate; DEAEM, 2-(diethylamino) ethyl methacrylate; NIPAAm, N-isopropylacrylamide; MBAM, N,N′-Methylenebis(acrylamide); YPLG, Tyr–Pro–Leu–Gly–NH.
Figure 1The mechanism of precipitation polymerisation.
Figure 2The mechanism of atom transfer radical polymerisation (ATRP) (a) and ATRPP (b). R-X, dormant species; Mtn, transition metal in its lower oxidation state; Mtn+1, transition metal in its higher oxidation state; Y, may be another ligand or the counterion; Mtn-Y/Ligand, transition metal complex; kact, rate constant of activation; kdeact, rate constant of deactivation; kp, rate constant of propagation; kt, rate constant of termination; ATRPP initiators, alkyl halide/CuCl/Ligand in normal ATRP or AIBN/CuCl2/Ligand in reverse ATRP.
Figure 3The mechanism of iniferter-induced ‘living’ radical polymerisation (ILRP) (a) and ILRPP (b). M, monomer; B, small radical; M*, propagating radical; B*, less reactive or nonreactive radical; PRT, primer radical termination; CT, chain transfer.
Figure 4The mechanism of the reversible addition-fragmentation chain transfer (RAFT) polymerisation (a), RAFTPP (b). M, monomer; (1), propagating radical; (2), thiocarbonylthio compound as RAFT agent; S, sulphur; R, free radical leaving-group that is capable of reinitiating polymerisation; Z, group that modifies the activity of the RAFT agent; (3), intermediate radical; (4), dormant species; (5), fragment radical.
Figure 5The mechanism of Pickering emulsion polymerisation.
Figure 6The mechanism of suspension polymerisation.
Advantages and disadvantages of different polymerisation technique in preparation of molecularly imprinted microspheres.
| Polymerisation Technique | Advantages | Diadvantages |
|---|---|---|
| Precipitation Polymerisation |
Easy to operate. Requires no stabiliser or surfactant. Good control of particle sizes and morphology. |
Commonly using high amount of solvent.1 Low control of polymerisation rate. Commonly do not possess ‘living’ groups on the polymer surface. |
| Controlled/‘living’ radical precipitation polymerisation (CRPP) 2 |
Requires no stabiliser or surfactant. High control of polymerisation rate, composition, and molecular weight. Able to do advanced surface modification because the presents of ‘living’ groups on the polymer surface. Can performed under mild reaction conditions | |
| Atom Transfer Radical Precipitation Polymerisation (ATRPP) |
Wide scope of monomer, initiator and catalyst utilization. The obtained MIMs are generally end-capped with a reactive halogen groups. Relatively low-cost. |
May has limited application due to the use of large amounts of acidic functional monomers or templates that could possibly deactivate the metal catalyst |
| Iniferter-induced ‘Living’ Radical Precipitation Polymerisation (ILRPP) |
Compatible with many molecular imprinting systems The obtained MIMs are generally end-capped with an iniferter groups. |
Less controlled compared to ATRPP and RAFTPP |
| Reversible Addition-Fragmentation Chain Transfer Precipitation Polymerisation (RAFTPP) |
Wide scope of monomers (nearly all monomers) The obtained MIMs are generally end-capped with a dithioester groups. Well suited for the preparation of high molecular weight polymers. |
The presence of dithioester groups makes the obtained MIMs coloured dan may have some odours for low molar mass species that might require radical chemistry for removal and displacement. The presence of a continuously generated new short chains which terminate faster than the longer chains. |
| Pickering Emulsion |
The addition of BPA can produce multi-hollow microsphere Require use of surfactants |
Have more possibility to coalescence between the droplets Concentrations of solid phase must be considered to avoid coalescence |
| Suspension Polymerisation |
Dispersing agent must be inert with the template, monomer, crosslinker and initiator Required use of special dispersing phases |
The template on MIMs in a polar solvent with aqueous suspension polymerisation have weaker covalent interactions with the monomer. |
1 Can be overcome using modified precipitation polymerisation (MPP); 2 Applied to ATRPP, ILRPP and RAFTPP.
Comparation of different polymerisation in preparation of molecularly imprinted microspheres.
| Template | Monomer | PP | ATRPP | RAFTPP | PE | ||||
|---|---|---|---|---|---|---|---|---|---|
| Binding Affinity | IF | Binding Affinity | IF | Binding Affinity | IF | Binding Affinity | IF | ||
| 17β-estradiol | MAA | More than 50% analyte [ | 2.3 [ | - | - | - | - | 30–60% analyte [ | 3.0 [ |
| 4-VP | 0.75 mg/g [ | 4.55 | 180.65 mg/g [ | 6.67–7.38 [ | - | - | - | - | |
| Nicotine | MAA | Not mention in the article [ | 10.5 [ | - | - | Not mention in the article | 3.33 [ | - | - |
| Bisphenol A | 4-VP | Not mention in the article | 3.91 [ | Not mention in the article | 10 [ | - | - | 1.32 mg/g [ | 6.5 [ |
PP, precipitation polymerisation; ATRPP, atom transfer radical precipitation polymerisation; RAFTPP, reversible addition-fragmentation chain transfer precipitation polymerisation; PE, Pickering emulsion polymerisation; IF, imprinting factor; MAA, methacrylic acid; 4-VP, 4-vinylpyridine; -, no resource found in related technique.